These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 34553650)

  • 41. Absorption, pharmacokinetics and disposition properties of solid lipid nanoparticles (SLNs).
    Wang J; Chen J; Ye N; Luo Z; Lai W; Cai X; Lin Y
    Curr Drug Metab; 2012 May; 13(4):447-56. PubMed ID: 22443539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Solid lipid nanoparticles for enhanced oral absorption: A review.
    Salah E; Abouelfetouh MM; Pan Y; Chen D; Xie S
    Colloids Surf B Biointerfaces; 2020 Dec; 196():111305. PubMed ID: 32795844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Solid lipid nanoparticles and their application in the treatment of bacterial infectious diseases.
    Arabestani MR; Bigham A; Kamarehei F; Dini M; Gorjikhah F; Shariati A; Hosseini SM
    Biomed Pharmacother; 2024 May; 174():116433. PubMed ID: 38508079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid-Based Nanoparticles as Oral Drug Delivery Systems: Overcoming Poor Gastrointestinal Absorption and Enhancing Bioavailability of Peptide and Protein Therapeutics.
    Mehrdadi S
    Adv Pharm Bull; 2024 Mar; 14(1):48-66. PubMed ID: 38585451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment.
    Graván P; Aguilera-Garrido A; Marchal JA; Navarro-Marchal SA; Galisteo-González F
    Adv Colloid Interface Sci; 2023 Apr; 314():102871. PubMed ID: 36958181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipid nanocarriers: influence of lipids on product development and pharmacokinetics.
    Pathak K; Keshri L; Shah M
    Crit Rev Ther Drug Carrier Syst; 2011; 28(4):357-93. PubMed ID: 21967401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Solid lipid nanoparticles for ocular drug delivery.
    Seyfoddin A; Shaw J; Al-Kassas R
    Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Solid Lipid Nanoparticles: Applications and Prospects in Cancer Treatment.
    Sivadasan D; Ramakrishnan K; Mahendran J; Ranganathan H; Karuppaiah A; Rahman H
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nano-Lipidic Carriers as a Tool for Drug Targeting to the Pilosebaceous Units.
    Ramkar S; Sah AK; Bhuwane N; Choudhary I; Hemnani N; Suresh PK
    Curr Pharm Des; 2020; 26(27):3251-3268. PubMed ID: 32410556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.
    Das S; Chaudhury A
    AAPS PharmSciTech; 2011 Mar; 12(1):62-76. PubMed ID: 21174180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Solid lipid nanoparticles as oral delivery systems of phenolic compounds: Overcoming pharmacokinetic limitations for nutraceutical applications.
    Nunes S; Madureira AR; Campos D; Sarmento B; Gomes AM; Pintado M; Reis F
    Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1863-1873. PubMed ID: 26192708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Solid lipid nanocarriers in drug delivery: characterization and design.
    Mu H; Holm R
    Expert Opin Drug Deliv; 2018 Aug; 15(8):771-785. PubMed ID: 30064267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
    Harde H; Das M; Jain S
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug targeting using solid lipid nanoparticles.
    Rostami E; Kashanian S; Azandaryani AH; Faramarzi H; Dolatabadi JE; Omidfar K
    Chem Phys Lipids; 2014 Jul; 181():56-61. PubMed ID: 24717692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent advances and patents on solid lipid nanoparticles.
    Sawant KK; Dodiya SS
    Recent Pat Drug Deliv Formul; 2008; 2(2):120-35. PubMed ID: 19075903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral nanoparticulate drug delivery systems for the treatment of intestinal bowel disease and colorectal cancer.
    Laffleur F; Mayer AH
    Expert Opin Drug Deliv; 2023; 20(11):1595-1607. PubMed ID: 38044874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterising lipid lipolysis and its implication in lipid-based formulation development.
    Thomas N; Holm R; Rades T; Müllertz A
    AAPS J; 2012 Dec; 14(4):860-71. PubMed ID: 22956477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation and characterization of solid lipid nanoparticles-a review.
    Parhi R; Suresh P
    Curr Drug Discov Technol; 2012 Mar; 9(1):2-16. PubMed ID: 22235925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Delivery of lipophilic bioactives: assembly, disassembly, and reassembly of lipid nanoparticles.
    Yao M; Xiao H; McClements DJ
    Annu Rev Food Sci Technol; 2014; 5():53-81. PubMed ID: 24328432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.